University of Hong Kong Featured PhD Programmes
University of West London Featured PhD Programmes
University College London Featured PhD Programmes

Integrative data analysis: from novel biomarker-drug response associations to predicting effective drug combinations


Centre for Childhood Cancer Research

, Applications accepted all year round Competition Funded PhD Project (Students Worldwide)

About the Project

More than 140 children with cancer die in Australia each year due to the occurrence of resistance to traditional chemotherapy. To improve overall survival rates for high-risk paediatric cancer patients, the Children’s Cancer Institute initiated the Zero Childhood Cancer national personalised medicine trial (PRISM). Within this trial, tumour biopsies from children with high-risk cancer are collected for full molecular profiling to identify cancer driver events and for the generation of patient-derived model systems to link these events to targeted therapies.
WGS, RNA-Seq and DNA methylation profiling of >350 tumour samples showed actionable events in only 70% of the patients. High-throughput drug testing on 85 patient-derived samples yielded unexpected efficacy patterns for single agent targeted drugs without an associated predictive biomarker, but clinical trials for paediatric cancer have proven that treatment with single agents is insufficient in most cases. The current study aims to integrate PRISM molecular profiling and in vitro drug efficacy datasets to identify novel biomarker-drug response associations and predict effective drug combinations for paediatric cancer by developing novel bioinformatic algorithms. Publicly available databases such as DepMap, CancerrXGene and NCI-ALMANAC that contain in vitro efficacy data for single drugs and drug combinations alongside molecular characterisation of the used model systems will be exploited for algorithm optimisation and deeper integrative analysis. Novel discovered biomarker-drug response associations and drug combinations will be validated in vitro and in vivo in patient-derived model systems to guide future clinical trials for paediatric cancer treatment.
To help us determine your suitability for postgraduate studies with us could you please send through a copy of your full academic transcript. All students at the Institute must fulfil the requirements for enrolment at UNSW to undertake their PhD with us as well as obtain a scholarship that will cover both your living expenses and tuition fees.

Funding Notes

All students at the Institute must fulfil the requirements for enrolment at UNSW to undertake their PhD with us as well as obtain a scholarship that will cover both your living expenses and tuition fees. Scholarship and entry requirements will be provided on request.

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here

The information you submit to Children’s Cancer Institute Australia will only be used by them or their data partners to deal with your enquiry, according to their privacy notice. For more information on how we use and store your data, please read our privacy statement.

* required field

Your enquiry has been emailed successfully



Search Suggestions

Search Suggestions

Based on your current searches we recommend the following search filters.



FindAPhD. Copyright 2005-2021
All rights reserved.